Clinical Trial Update: Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nimotuzumab in combination with chemoradiation for locally advanced rectal cancer; the update provides no results or current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN